We are live on ! Find out more
RNVAZ

Rennova Health, Inc. Warrant

Delisted

RNVAZ was delisted on the 24th of October, 2017.

4 hedge funds and large institutions have $92K invested in Rennova Health, Inc. Warrant in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

20% less funds holding

Funds holding: 54 (-1)

28% less capital invested

Capital invested by funds: $128K → $92K (-$36K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VKH
1
Virtu KCG Holdings
New York
$43K +$13.9K +720,614 +1,053%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$30K +$462 +23,943 +5%
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$17K -$5.1K -264,260 -47%
UBS Group
4
UBS Group
Switzerland
$2K +$169 +8,765 +42%
SM
5
Sabby Management
Florida
-$105K -5,249,822 Closed

RNVAZ Hedge Fund Activity: Q2 2017 in Review

4 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. Warrant (RNVAZ) for Q2 2017, worth a combined $92K — down 28% from $128K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of RNVAZ and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.

The largest buyer was Virtu KCG Holdings, adding an estimated $13.9K. The largest seller was Sabby Management, exiting entirely with an estimated $105K sold.

  • 4 institutional investors held Rennova Health, Inc. Warrant (RNVAZ) as of Q2 2017, down from 5 in Q1 2017.
  • Funds reported $92K of Rennova Health, Inc. Warrant stock for Q2 2017, down 28% quarter-over-quarter.
  • 0 funds opened new Rennova Health, Inc. Warrant positions in Q2 2017 and 1 closed out, a net change of -1 holder.
  • The largest Rennova Health, Inc. Warrant buyer in Q2 2017 was Virtu KCG Holdings, an estimated $13.9K added.
  • The largest Rennova Health, Inc. Warrant seller in Q2 2017 was Sabby Management, an estimated $105K sold.

Based on aggregated 13F filings for Q2 2017.